Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Phase I Study Of Cremophor FreePaclitaxel Nanoparticle In Advanced Breast Cancer

NCT00915369 is registered in ClinicalTrials.gov with Fresenius Kabi Oncology Ltd. as lead sponsor.

NCT NCT00915369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00915369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Phase I Study Of Cremophor FreePaclitaxel Nanoparticle In Advanced Breast Cancer
Lead sponsor
Fresenius Kabi Oncology Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2009
Completion date
April 30, 2010
Enrollment
24 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer